Innoviva INVA
NASDAQ INVA
$21.33 -0.02 (-0.09%)
As of: Sep 4, 2026 · 3:59 PM EDT

Innoviva (INVA) Long-Term Deferred Tax (2011 - 2025)

Innoviva's (INVA) quarterly Long-Term Deferred Tax came in at $8.0 million in Q3 2025, down 46.34% YoY from $14.9 million in Q3 2024, and down 38.27% on a QoQ basis from $12.9 million in Q2 2025.

Analysis

Innoviva (INVA) Long-Term Deferred Tax (2011 - 2025) Analysis & Trends

Innoviva (INVA) has 10 years of Long-Term Deferred Tax data on file, last reported at $8.0 million in Q3 2025.

  • Quarterly Long-Term Deferred Tax fell 46.34% year-over-year to $8.0 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $8.0 million (down 46.34% YoY) and the FY2025 annual result came in at $8.0 million, down 46.34% from the prior year.
  • Long-Term Deferred Tax declined to $8.0 million in Q3 2025, from $12.9 million in the prior quarter.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $74.0 million in Q1 2021 to a low of $5.0 million in Q3 2023.
  • A 5-year average of $21.2 million and a median of $13.9 million in 2024 frame the typical range for Long-Term Deferred Tax.
  • Annual changes were most pronounced in 2021 — Long-Term Deferred Tax slumped 81.52% — and 2024, when it jumped 200.38%.
  • Tracing INVA's Long-Term Deferred Tax over 5 years: stood at $17.3 million in 2021, then jumped by 34.32% to $23.3 million in 2022, then sank by 78.72% to $5.0 million in 2023, then surged by 143.42% to $12.1 million in 2024, then sank by 33.78% to $8.0 million in 2025.
  • The last three Long-Term Deferred Tax figures came in at $8.0 million (Q3 2025), $12.9 million (Q2 2025), and $12.3 million (Q1 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Innoviva 1.56 Bn 984.81 Mn 90.62 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 7.98 Mn
Jun 30, 2025 12.93 Mn
Mar 31, 2025 12.29 Mn
Dec 31, 2024 12.05 Mn
Sep 30, 2024 14.88 Mn
Jun 30, 2024 11.45 Mn
Sep 30, 2023 4.95 Mn
Jun 30, 2023 6.33 Mn
Jun 30, 2022 23.27 Mn
Mar 31, 2022 22.40 Mn
Dec 31, 2021 17.33 Mn
Sep 30, 2021 28.16 Mn
Jun 30, 2021 48.69 Mn
Mar 31, 2021 74.02 Mn
Dec 31, 2020 93.76 Mn
Sep 30, 2020 109.49 Mn
Jun 30, 2020 118.35 Mn
Mar 31, 2020 138.24 Mn
Dec 31, 2019 154.17 Mn
Sep 30, 2019 166.56 Mn